| Pharmaceutical active ingredients: |
| Ondansetron Hydrochloride Dihydrate |
| Available forms, composition and doses of Ondansetron: |
| Injectable; Injection; Ondansetron Hydrochloride Dihydrate 2 mg / ml |
| Ondansetron medical category: |
| Human:5-HT3 Receptor AntagonistsAntiemeticsSupportive care therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A04AA01 - Ondansetron |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Hospira |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Novo-Ondansetron | Ondansetron Hydrochloride Dihydrate | Novopharm |
| Ondansetron | Ondansetron Hydrochloride Dihydrate | AA Pharma |
| Ondansetron | Ondansetron Hydrochloride Dihydrate | Aguettant |
| Ondansetron | Ondansetron Hydrochloride Dihydrate | Cipla |
| Ondansetron | Ondansetron Hydrochloride Dihydrate | Dakota Pharma |
| Ondansetron | Ondansetron Hydrochloride Dihydrate | Meliapharm |
| Ondansetron | Ondansetron Hydrochloride Dihydrate | Novopharm |
| Ondansetron | Ondansetron Hydrochloride Dihydrate | Novosibkhimfarm |
| Ondansetron | Ondansetron Hydrochloride Dihydrate | Omega Laboratories |
| Ondansetron | Ondansetron Hydrochloride Dihydrate | Pharma Strides Canada Corporation |